SelectQuote (SLQT) Q4 2026 Earnings Call Summary

1Key Financial Results and Metrics

Fiscal Year 2026 Revenue: $1.62 billion, up 6% year-over-year.

Q4 Revenue: $322 million, down from $345 million in Q4 2025.

Adjusted EBITDA: $109 million for the year, exceeding guidance of $90-$100 million; Q4 adjusted EBITDA increased to $12 million from $3 million year-over-year.

Operating Cash Flow: Improved by $44 million year-over-year, with expectations to exceed $60 million in FY 2027.

Senior Business Revenue: $576 million, down 4% year-over-year, but maintained a 26% adjusted EBITDA margin.

Healthcare Services Revenue: $845 million, up 14% year-over-year, with an adjusted EBITDA of $25 million, exiting Q4 at a nearly $50 million annual run rate.

2Strategic Updates and Business Highlights

SelectQuote's focus is on driving profitable cash flow and reducing leverage, emphasizing cash generation over mere growth.

The Healthcare Services division has become the largest revenue contributor and is expected to enhance cash flow and earnings power in FY 2027.

The company is implementing over $30 million in annualized expense improvements through technology and operational efficiencies, including AI and a new pharmacy management system.

The Kansas facility is achieving 30% efficiency gains, which is expected to enhance margins and cash flow.

3Forward Guidance and Outlook

FY 2027 Revenue Guidance: $1.35 billion to $1.45 billion, reflecting a 14% decline at the midpoint due to a conservative approach in the Medicare Advantage (MA) market.

Adjusted EBITDA Guidance for FY 2027: $90 million to $115 million, with expectations of margin expansion.

Operating Cash Flow: Expected to approximately double to over $60 million in FY 2027, with a target of around $50 million in free cash flow.

The company anticipates a decline of 10% to 15% in approved policies for the Senior business due to a transitional year in the MA market.

4Bad News, Challenges, or Points of Concern

The Senior business faced a 4% revenue decline due to a challenging MA environment and reduced marketing investments from key carrier partners.

The impact of the Inflation Reduction Act is expected to create revenue headwinds in Healthcare Services, particularly in the first half of FY 2027.

The MA market remains volatile, with ongoing adjustments from carriers affecting growth opportunities.

The company is being prudent with growth investments, which may limit short-term revenue growth.

5Notable Q&A Insights

Management acknowledged the synergistic relationship between the Senior and Healthcare Services divisions but emphasized a focus on operational efficiency and margin improvement amid a pullback in the Senior business.

There are opportunities for membership growth outside the Senior market, but the primary focus remains on improving margins and cash flow.

The company expects to maintain high conversion rates in the Senior business due to a more experienced agent workforce, despite a slight decline in overall policy volumes.

Management expressed confidence in the long-term cash flow generation capabilities of the business, with a clear path to deleveraging and reducing the cost of capital. Overall, SelectQuote's Q4 2026 results reflect a commitment to cash flow generation and operational efficiency, despite facing headwinds in the Medicare Advantage market. The company is strategically positioned for future growth while prioritizing profitability and shareholder value.